CLSI Releases New Proposed Guidelines for Review and Comment CLSI releases new proposed guidelines for review and comment presentation of a manufacturer's risk mitigation information for users of in vitro diagnostic devices (EP22-P) and laboratory quality control based on risk management (EP23-P). 2/5/2010
AACE Approves New Diagnosis for Diabetes The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. 2/4/2010
McKesson Offers Cost Incentives to Encourage EHR Adoption As part of its Achieve HIT stimulus program for physicians, McKesson announced a limited-time offer to reduce the cost barriers associated with independent physician adoption of electronic health records (EHRs). 2/3/2010
Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor (TNF)-antagonist drug. 2/1/2010
Asuragen Collaborates with Top Researchers for Pancreatic Cancer Test Asuragen Inc announces that it has entered into research agreements with several hospitals and universities to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies. 2/3/2010
Experts here are available to answer all your questions!
Sandy Laughlin
